Embed Size (px)
Citation preview
Animal use in biologics development, production, and testingImplementing Nonanimal Approaches to Human and Veterinary Vaccine Testing: Achieving Scientific and Regulatory Success for Rabies and Beyond
October 10, 2018
Jeffrey [email protected]
2
PETA International Science Consortium
3
PETA International Science Consortium
See full list of publications at PISCLtd.org.uk/SciPubs
o Progress and problems• 3Rs policies for rabies vaccines (etc.)• Tracking animal use and 3Rs policy implementation• “Peripheral” animal use
o Progress to come• Antibody production• Pyrogen testing
4
Outline
2011 rabies vaccine workshop
5
2011 rabies vaccine workshop
6
2011 rabies vaccine workshop: NIH test problems
7
o ~200 mice per test
o ~50% experience significant unrelieved pain prior to euthanasia
o Up to 42% of tests invalid, must be repeated
o Up to 400% differences in estimated potency
Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamka A, Miller T, Brown K, Lewis C, Capsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinkel L, Jones B. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals. 2012;40(5):369-381.
NIH test
8Bruckner L, Cussler K, Halder M, Barrat J, Castle P, Duchow K, Gatewood DM, Gibert R, Groen J, Knapp B, Levis R, Milne C, Parker S, Stünkel K, Visser N, Volkers P; ECVAM. Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM workshop 48. Altern Lab Anim. 2003; 31(4):429-454.
NIH test
9Bruckner L, Cussler K, Halder M, Barrat J, Castle P, Duchow K, Gatewood DM, Gibert R, Groen J, Knapp B, Levis R, Milne C, Parker S, Stünkel K, Visser N, Volkers P; ECVAM. Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM workshop 48. Altern Lab Anim. 2003; 31(4):429-454.
o Implementation strategy to:o Replace NIH test with ELISA and/or SNT
• EPAA pre-validation study and EDQM international collaborative study
o Reduce numbers of mice used to meet NIH test requirements• USDA Center for Veterinary Biologics (CVB) Notice 13-10,
eliminates upper limit LD50 for a valid challengeo Reduce pain for mice used in NIH test
• USDA SAM 308 revised, allows anesthesia for mice prior to virus injection
• USDA CVB Notice 12-12, firms encouraged to use anesthesia prior to virus injection (etc.)
2011 rabies vaccine workshop: Progress
10Stokes W, McFarlandR, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamka A, Miller T, Brown K, Lewis C, Capsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinkel L, Jones B. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals. 2012;40(5):369-381.
o Implementation strategy to:o Replace NIH test with ELISA and/or SNT
• EPAA pre-validation study and EDQM international collaborative study
o Reduce numbers of mice used to meet NIH test requirements• USDA Center for Veterinary Biologics (CVB) Notice 13-10,
eliminates upper limit LD50 for a valid challengeo Reduce pain for mice used in NIH test
• USDA SAM 308 revised, allows anesthesia for mice prior to virus injection
• USDA CVB Notice 12-12, firms encouraged to use anesthesia prior to virus injection (etc.)
2011 rabies vaccine workshop: Progress
11Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamka A, Miller T, Brown K, Lewis C, Capsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinkel L, Jones B. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals. 2012;40(5):369-381.
Problems: counting animals
12
Problems: counting animals
13
Laboratory Animal Welfare Act of 1966, P.L. 89-544
o Required to carry out NIH test• Virus propagation: birds, mice, hamsters
o Required to meet product standard requirements• Immunogenicity: target species• Purity: mice• Safety: mice, rabbits, other species• Duration of immunity: target species
o “Peripheral” animals used in experiments• Antibody sources• Serum sources• Pyrogen testing
Problems: Not just the NIH test
14
Problems: Animal-derived antibodies
15Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamka A, Miller T, Brown K, Lewis C, Capsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinkel L, Jones B. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals. 2012;40(5):369-381.
Problems: Animal-derived antibodies
16
Groff K, Brown J, Clippinger AJ. Modern affinity reagents: recombinant antibodies and aptamers. Biotechnol Adv. 2015;33(8):1787-1798.
Problems: Animal-derived antibodies
17
Image: PETA US
Progress to come: recombinant antibodies
18
o Phage display
Progress to come: recombinant antibodies
19
Bradbury A, Plückthun A. Reproducibility: Standardize antibodies used in research. Nature. 2015;518(7537):27-29.
Progress to come: recombinant antibodies
20
Bradbury A, Plückthun A. Reproducibility: Standardize antibodies used in research. Nature. 2015;518(7537):27-29.
Progress to come: recombinant antibodies
21
Progress to come: recombinant antibodies
22
Animal use: antibody sources
23
Images: USDA Inspection Reports
Animal use: antibody sources
24
Images: USDA Inspection Reports
Animal use: antibody sources
25
Images: USDA Inspection Reports
Animal use: antibody sources
26
Images: USDA Inspection Reports
Animal use: antibody sources
27
Images: USDA Inspection Reports
Animal use: antibody sources
28
Images: PETA India
Animal use: antibody sources
29Images: PETA India
Animal use: antibody sources
30
Images: PETA India
Progress to come: replacing animal antibodies
31
o Datmab project• Phage display, select recombinant human antibodies against
diphtheria toxin• Assess toxin neutralization of toxin binding antibodies• Convert neutralizing antibodies with best binding affinity to IgG • Freeze-dry formulation and stability testing • Public health stakeholders, further development
Progress to come: pyrogen testing
32
Images: Cruelty Free International; Timothy Fadek / Corbis / Getty; The Atlantic
Progress to come: pyrogen testing
33
Zhang S. The Last Days of the Blue-Blood Harvest. The Atlantic. May 9, 2018.
Progress to come: pyrogen testing
34
Image: Merck
Summary
35
o Success is difficult to quantifyo How to measure impact of animal replacement,
reduction, refinement policies?
o NIH test replacement is within reacho Improved antibody sources should be prioritised
o Antibody production → recombinant methodso Research, diagnostic, and therapeutic relevance
o Ensuring use of other available replacementso RPT/BET → MAT
Contact: Jeffrey Brown
@PISCLtd
